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        Ischemia/reperfusion (I/R) injury is character-
ized by several cellular events, including the 
release of tissue enzymes, oxidative modifi  cation 
of essential proteins and lipids, and a dysregu-
lated infl  ammatory response, which ultimately 
leads to tissue necrosis and apoptosis (  1, 2  ). On 
a subcellular level, the mitochondrion is vital 
to tissue viability, and mitochondrial damage 
plays a central role in the progression of pa-
thology after I/R. During I/R, mitochondrial 
ATP synthesis is decreased (leading to deple-
tion of tissue high-energy phosphate stores) (  3  ), 
enzymes of the respiratory chain are damaged 
(leading to diminished inner membrane po-
tential) (  4, 5  ), the permeability transition pore 
is opened (  6  ), and upon reperfusion, reactive 
oxygen species (ROS) generation is increased. 
The mechanisms underlying cytoprotection of 
a large number of I/R therapeutic agents in-
volves the regulation of mitochondrial function 
either through the modulation of membrane 
potential, ROS formation, or the activity of 
the ATP-sensitive potassium channel. Accu-
mulating data suggest that modulation of mito-
chondrial function is particularly important in 
ischemic preconditioning, where cytoprotec-
tion is evident from hours to days after the 
nonlethal ischemia-activated cell-survival pro-
grams (  5, 7  ). 
  The circulating molecule nitrite (NO  2         ) has 
been shown to mediate potent cytoprotection 
after I/R injury in the heart, liver, and brain 
when administered during ischemia or imme-
diately before reperfusion (  8  –  11  ). For example, 
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  Nitrite (NO  2         ) is an intrinsic signaling molecule that is reduced to NO during ischemia and 
limits apoptosis and cytotoxicity at reperfusion in the mammalian heart, liver, and brain. 
Although the mechanism of nitrite-mediated cytoprotection is unknown, NO is a mediator 
of the ischemic preconditioning cell-survival program. Analogous to the temporally distinct 
acute and delayed ischemic preconditioning cytoprotective phenotypes, we report that both 
acute and delayed (24 h before ischemia) exposure to physiological concentrations of 
nitrite, given both systemically or orally, potently limits cardiac and hepatic reperfusion 
injury. This cytoprotection is associated with increases in mitochondrial oxidative 
phosphorylation. Remarkably, isolated mitochondria subjected to 30 min of anoxia followed 
by reoxygenation were directly protected by nitrite administered both in vitro during 
anoxia or in vivo 24 h before mitochondrial isolation. Mechanistically, nitrite dose-
dependently modifi  es and inhibits complex I by posttranslational S-nitrosation; this dampens 
electron transfer and effectively reduces reperfusion reactive oxygen species generation 
and ameliorates oxidative inactivation of complexes II  –  IV and aconitase, thus preventing 
mitochondrial permeability transition pore opening and cytochrome c release. These data 
suggest that nitrite dynamically modulates mitochondrial resilience to reperfusion injury 
and may represent an effector of the cell-survival program of ischemic preconditioning and 
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cytoprotection when administered during ischemia or im-
mediately before reperfusion (  8, 9  ), it is not known whether 
nitrite can temporally replicate delayed preconditioning. To 
test this, mice were administered one bolus intraperitoneal 
injection of nitrite (48 nmol) or saline and subjected to either 
myocardial infarction or hepatic ischemia 24 h later (  Fig. 
1 A  ).   After hepatic I/R, serum alanine aminotransferase 
(ALT) levels, representing hepatic injury, increased (525      
40 U/liter) compared with sham surgical controls (50      10 
U/liter). Nitrite administered both acutely and 24 h before 
ischemia attenuated the increase in ALT (210 and 220      30 
U/liter, respectively) to a similar degree (  Fig. 1 B  ). Simi-
larly, nitrite administration acutely or 24 h before ischemia 
signifi  cantly reduced myocardial infarct size (18      4 and 
35      14%, respectively) compared with saline-treated mice 
(53      5%;   Fig. 1, C and D  ). Thus nitrite exerts potent cyto-
protective eff  ects after I/R injury temporally analogous to 
ischemic preconditioning. 
  Nitrite-dependent protection occurs 
at the mitochondrial level 
  To elucidate the mechanism of cytoprotection in the heart 
and liver, we examined mitochondria isolated from the liver 
of mice after hepatic I/R and polarographically measured 
their respiratory rate. State 3 respiratory rates, using succinate 
as a substrate, correlated inversely with the measured ALT 
levels. Mice subjected to sham surgery in the presence and 
absence of nitrite had the lowest ALT levels and the highest 
mitochondrial respiratory rates (34  –  40 nmol O  2  /min/mg of 
protein), whereas those subjected to I/R showed an     50% 
decrease in respiratory rate (18      4 nmol O  2  /min/mg). Ni-
trite administration (48 nmol) during or 24 h before ischemia 
increased state 3 succinate-dependent mitochondrial respira-
tion (25      2 and 27      2 nmol O  2  /min/mg, respectively) after 
I/R (  Fig. 2 A  ).   
  In an attempt to evaluate whether this protection occurs 
at the mitochondrial level versus an eff  ect on cellular injury 
resulting in secondary, indirect mitochondrial protection, we 
examined isolated rat mitochondria in the absence of other 
cellular organelles subjected to an in vitro model of I/R injury. 
In these experiments, mitochondria isolated from rat liver were 
used because of their robust activity and abundant quantity in 
comparison with mitochondria isolated from mice. The mito-
chondria (1 mg/ml) were stimulated to respire in state 3 
through complex II by the addition of 5 mM succinate and 
1 mM ADP until all the oxygen in the chamber was consumed. 
After 30 min of anoxia, the mitochondria were reoxygenated, 
washed, and resupplied with substrate. The mitochondrial re-
spiratory rate was decreased by     50% in comparison with the 
preanoxic respiratory rate and compared with control mito-
chondria suspended in normoxic buff  er for 30 min (  Fig. 2, 
B and C  ). This diminished respiratory rate recapitulates that 
seen in vivo and implicates mitochondrial damage induced by 
anoxia/reoxygenation. The isolated mitochondrial experi-
ments were then repeated after one intraperitoneal injection of 
either nitrite (480 nmol) or saline to rats 24 h before hepatic 
in murine models of myocardial and hepatic infarction, 
nanomole doses (1.2  –  48 nmol) of nitrite reduced infarction 
volume and apoptosis by     50% compared with controls 
(  8, 11  ); similar eff  ects have been observed in the isolated per-
fused rat heart (  10  ). More recently, in a rat model of stroke, 
48  –  480 nmol of nitrite reduced cerebral infarct volume by 
    75% and enhanced neurological functional recovery (  9  ). 
Although the eff  ects of nitrite are undoubtedly potent, the 
mechanisms orchestrating cytoprotection are unknown. 
  Emerging data demonstrate that nitrite is an important 
endocrine reservoir of NO that is reduced to bioactive NO 
along a physiological pH and oxygen gradient by several 
mechanisms, including enzymatic reduction by hemoglobin, 
myoglobin (  12–14  ), components of the mitochondrial respi-
ratory chain (  15  ), and xanthine oxidoreductase (  16  ), as well 
as nonenzymatically by acidic disproportionation (  17, 18  ). 
Although NO is known to protect tissues from I/R injury, 
its therapeutic window is limited in terms of dose, source, 
and duration of exposure (  19  –  23  ). In addition, the ability 
of the enzyme NO synthase to generate NO during I/R is 
compromised because of the requirement for oxygen as a 
substrate. Conversely, the conditions during I/R when oxy-
gen is limiting and the tissue becomes acidotic are optimal 
for the reduction of nitrite to NO. Consistent with the idea 
of nitrite-dependent NO generation during I/R, the NO 
scavenger 2-phenyl-tetramethylimidazoline-1-oxyl-3-oxide 
(PTIO) reversed nitrite-dependent cytoprotection in all pre-
viously published studies (  8  –  10  ). 
  NO is a well-characterized regulator of mitochondrial 
function, with nanomolar concentrations reversibly inhibit-
ing cytochrome c oxidase (  24, 25  ), regulating ROS forma-
tion (  26, 27  ), initiating biogenesis (  28, 29  ), and limiting 
apoptotic cytochrome c release (  30, 31  ). Given the central 
role of mitochondria during I/R, as well as the concept that 
its modulation may enhance ischemic tolerance during 
preconditioning, we hypothesized that (a) the cytoprotective 
eff  ects of nitrite mimic and may mediate the ischemic pre-
conditioning cell-survival program and that (b) the cytopro-
tective eff  ects of nitrite occur at the level of the mitochondrion, 
by enhancing reperfusion respiration and energetics and 
limiting ROS-mediated cellular dysfunction. Finally, con-
sidering the fact that nitrate intake in the Mediterranean 
diet is associated with both nitrite uptake into plasma and 
a reduction in cardiovascular morbidity and mortality, we 
evaluated whether dietary nitrite may modulate the organ 
response to I/R. 
    RESULTS   
  Nitrite mimics ischemic preconditioning in vivo 
  Transient nonlethal ischemia, termed the ischemic precon-
ditioning   “  trigger,  ”   evokes cellular resilience to I/R (  32  ). 
Importantly, there exist two temporal windows of I/R tol-
erance: acute, or classical, ischemic preconditioning, lasting 
minutes to a few hours after the ischemic trigger, and delayed 
ischemic preconditioning, evident 1  –  3 d after the transient 
ischemic trigger. Although nanomole doses of nitrite mediate JEM VOL. 204, September 3, 2007 
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  Nitrite does not regulate mitochondrial biogenesis 
  Because the half-life of nitrite in blood is only 11 min (  33  ), 
we considered that nitrite may mimic delayed preconditioning 
through the transcriptional regulation of nuclear-encoded mito-
chondrial functioning genes (  34, 35  ). Moreover, recent studies 
have shown that NO activates the mitochondrial biogenesis 
regulatory program (  28, 29  ). To explore this possibility, we 
evaluated the gene expression profi  les in response to daily nitrite 
administration for 1, 2, 3, and 9 d before mRNA extraction. 
The gene expression profi  les of the nuclear genes encoding 
mitochondrial biogenesis regulatory proteins, antioxidant en-
zymes, uncoupling proteins, and respiratory chain enzymes were 
quantifi  ed. Although nitrite-dependent protection was main-
tained in the mitochondria throughout this exposure time (  Fig. 
3, A and B  ), nitrite-treated rats showed no change in mRNA 
expression of genes encoding transcriptional regulators of the 
mitochondrial biogenesis program (PGC-1     and NRF2), respi-
ratory proteins (cytochrome c oxidase, cytochrome c, and ade-
nine nucleotide translocase), or in antioxidant defense mediators 
mitochondrial isolation. Although the preanoxic complex 
II-dependent respiratory rate was similar with and without 
prior nitrite administration (85      12 and 80      10 nmol O  2  /
min/mg, respectively), mitochondria from the nitrite-treated 
rats had signifi  cantly higher postanoxic respiration rates (67      
12 nmol O  2  /min/mg) versus saline-treated rats (45      6 nmol 
O  2  /min/mg;   Fig. 2 C  ). Examination of the pre- and postan-
oxic rates demonstrates that the saline group sustained a 48      
6% drop in respiration rate, whereas the nitrite group decreased 
by only 20      4% (  Fig. 2 D  ). 
  To exclude mitochondrial uncoupling as a major compo-
nent in diff  erential postanoxia respiratory rates, the rate of 
ATP formation was determined. Preanoxic rates of ATP pro-
duction were similar with or without nitrite administration. 
However, after anoxia, mitochondria from the saline-treated 
rats recovered 52      4% of ATP synthesis, whereas mitochon-
dria from nitrite-treated rats recovered 78      2% (  Fig. 2 E  ). 
These data suggest that nitrite-mediated delayed cytoprotec-
tion occurs at the level of the mitochondrion. 
  Figure 1.     Nitrite mediates both acute and delayed cytoprotection after I/R injury to the heart and liver. (A) Model of hepatic ischemia and 
myocardial infarction in which nitrite or saline was administered either 24 h before or during ischemia. (B) Plasma ALT levels 5 h into reperfusion in mice 
after sham surgery, sham surgery with nitrite treatment, ischemia with acute nitrite treatment, or ischemia with nitrite preconditioning (PC). (C) Infarct 
size as a percentage of area at risk 24 h after myocardial infarction in the absence of nitrite (I/R), with nitrite treatment 5 min before reperfusion (acute), 
or nitrite treatment 24 h before myocardial infarction (PC). (D) Representative sections of myocardium stained with Evan  ’  s blue and triphenyltetrazolium 
chloride 24 h after infarction in mice receiving no nitrite (I/R  vehicle), acute nitrite treatment, or nitrite preconditioning. *, P      0.05 in comparison with 
the I/R  vehicle group; **, P      0.01 versus the I/R  vehicle group.     2092 NITRITE PROTECTS FROM I/R INJURY BY REGULATING MITOCHONDRIA | Gladwin et al.
delayed cytoprotection cannot be completely excluded with-
out further study. 
  Acute in vitro nitrite treatment protects mitochondria 
from I/R injury 
  The lack of evidence for nitrite-dependent regulation of 
mitochondrial protein expression suggested that the protec-
tive eff  ect of nitrite on mitochondria was most likely caused 
by the posttranslational modifi  cation of existing mitochon-
drial proteins. We hypothesized that if posttranslational 
modifi  cation was indeed responsible, mitochondrial protec-
tion of respiration and ATP synthesis should be observed 
even with acute nitrite treatment of mitochondria in vitro. 
To test this, we subjected isolated mitochondria from un-
treated rats to 30 min of anoxia followed by reoxygenation 
(catalase, superoxide dismutase, and uncoupling protein 2) in 
comparison with saline-treated rats (  Fig. 3 C  ).   Mitochondrial 
protein expression (  Fig. 3 D  ) and mitochondrial number and 
morphology (unpublished data) remained constant despite nine 
consecutive days of nitrite treatment. These data show that 
nitrite-dependent protection is not mediated by changes in 
gene transcription or translation that directly modulate the 
mitochondrial biogenesis program. Similarly, a single dose of 
nitrite administered 5 h before the extraction of hepatic tissue 
demonstrated no signifi  cant up-regulation of genes encoding 
cyclooxygenase-2 and inducible NO synthase (iNOS; 1.66  
0.02 fold change [P  0.08] and 1.335  0.09 fold change 
[P  0.23], respectively;   n    10). As cyclooxygenase-2 and 
iNOS are established mediators of delayed preconditioning 
(  36  ), a partial role of this signaling cascade in nitrite-dependent 
  Figure 2.     Nitrite preconditioning protects from ischemic damage at the mitochondrial level. (A) Respiratory rates (in the presence of succinate 
and ADP) of liver mitochondria isolated from mice 5 h after being subjected to hepatic I/R in the presence and absence of acute and preconditioning nitrite. 
(B) In vitro model of mitochondrial anoxic/reoxygenation. Red trace is mitochondria subjected to anoxia. Blue trace is mitochondria subjected to normoxia for 
30 min. (C) Representative respiration traces of 1 mg/ml of mitochondria isolated from rats preconditioned with saline (continuous lines) or 480 nmol nitrite (dashed 
lines) before (green) and after (blue) anoxia. (D and E) Postanoxic respiration (D) and ATP synthesis (E) rates expressed as a percentage of preanoxic rate for 
mitochondria isolated from rats preconditioned with saline or nitrite. All experiments are means      SEM of at least   n    3 independent experiments. *, P      0.01.   JEM VOL. 204, September 3, 2007 
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  It is well established that modulation of mitochondrial 
ATP-dependent potassium (K  ATP  ) channels during I/R can 
aff  ect tissue viability. To determine whether nitrite mediates 
cytoprotection by regulating K  ATP   channels, we tested the 
eff  ects of nitrite treatment during anoxia/reoxygenation in 
the presence of diazoxide, a K  ATP   channel opener, and gliben-
clamide, an inhibitor of this channel. In our model, opening 
of the K  ATP   channel with 200   	  M diazoxide was protective, 
with a 63      6% recovery of respiration after anoxia in com-
parison with 42      5% in the control. Likewise, inhibition of 
the K  ATP   channel with 100   	  M glibenclamide resulted in a 
signifi  cant decrease in postanoxic recovery of respiration (22      
3%). Although both of these pharmacologic agents had inde-
pendent eff  ects on postanoxic respiration rates, neither drug 
inhibited nitrite-dependent protection of mitochondria (  Fig. 
5 A  ), suggesting that the K  ATP   channel was not the target for 
nitrite-mediated cytoprotection.   
in the presence and absence of nitrite (  Fig. 4 A  ).   As predicted, 
nitrite-treated (10   	  M) mitochondria had both higher com-
plex II  –  dependent state 3 respiration (78      12 nmol O  2  /
min/mg;   Fig. 4, A and B  ) and ATP production (16      6 rel-
ative light units/s;   Fig. 4, C and D  ) rates than control mito-
chondria (54      4 nmol O  2  /min/mg and 9.8 relative light 
units/s, respectively) after anoxia/reoxygenation. Interest-
ingly, nitrite-dependent protection from the anoxia-induced 
drop in respiration rate showed a biphasic dose  –  response 
curve (0  –  100   	  M), with peak protection occurring at a 
concentration of 12.5   	  M (  Fig. 4 E  ). This biphasic response 
is identical in shape and concentration to previously ob-
served dose  –  response curves for nitrite-mediated cytopro-
tection in vivo, and the concentration of 12.5   	  M nitrite 
conferring peak protection to the mitochondria parallels the 
tissue concentration of nitrite shown to orchestrate peak 
protection in vivo (  8  ). 
  Figure 3.     Nitrite-dependent cytoprotection does not modulate mitochondrial biogenesis. Rats were given one intraperitoneal injection (480 nmol) 
of saline or nitrite daily for nine consecutive days. (A and B) Recovery of respiration (A) and ATP (B) generation rates of mitochondria isolated from 
these rats after 30 min of anoxia in vitro (white, saline; green, nitrite). (C) Relative expression of genes in the livers of nitrite-treated rats on day 9 pre-
sented as the fold change in gene expression compared with saline-treated rats. (D) Protein expression of the 39-kD subunit of complex I, cytochrome c, 
and ATPase subunit B in the livers of rats after 9 d of nitrite or saline treatment. All experiments are means      SEM of at least   n    3 independent experi-
ments. *, P      0.01.   2094 NITRITE PROTECTS FROM I/R INJURY BY REGULATING MITOCHONDRIA | Gladwin et al.
not enhanced, by nitrite treatment during anoxia/reoxy-
genation (  Fig. 5 B  ). Interestingly, the same eff  ect was ob-
served in the postanoxic respiration rate of mitochondria 
isolated from rats treated with 480 nmol nitrite 24 h before 
isolation, though there was no signifi  cant eff  ect of nitrite 
treatment on preanoxic respiration rate (  Fig. 5 C  ). This 
trend was recapitulated in mitochondria isolated from mice 
that were subjected to hepatic I/R in vivo ( Fig. 5 D ). Spectro-
photometric measurement of complex I  –  dependent oxi-
dation of NADH confi  rmed that nitrite treatment (0  –  100   	  M) 
of isolated mitochondria during anoxia concentration-
  dependently inhibited the enzymatic activity of complex I 
(  Fig. 5 E  ), whereas we saw no substantial eff  ect on the isolated 
activities of complex II or IV (unpublished data). 
  NO can S-nitrosate critical thiols on complex I, leading 
to an inhibition of its activity (  38  –  40  ). This inhibition of 
complex I is proposed to exert cytoprotection during I/R, 
  Nitrite inhibits complex I after I/R 
  Although we have observed a nitrite-dependent protection 
of the complex II respiratory rate after anoxia/reoxygen-
ation, it is important to also consider the eff  ects of nitrite 
on complex I  –  dependent respiration, because complex I is 
known to be a primary site of both injury and ROS pro-
duction after I/R (  37  ). To test the eff  ects of nitrite on com-
plex I, we measured glutamate/malate-supported (5 mM 
each) state 3 respiration in isolated mitochondria before and 
after anoxia/reoxygenation. After anoxia/reoxygenation, 
both complex I  –   and II  –  supported respiration showed a de-
crease in respiration rate, though complex I showed a much 
greater decrease in rate (62      4 vs. 35      3% recovery), 
consistent with the increased susceptibility of complex I to 
I/R damage. However, in contrast to observed eff  ects on 
complex II respiration, respiration through complex I was 
inhibited (20 vs. 35% recovery in control mitochondria), 
  Figure 4.     Acute nitrite treatment protects mitochondria against I/R injury. (A) Model of in vitro mitochondrial damage showing preanoxic (green) 
and postanoxic rates in the absence (blue) and presence (red) of nitrite. Arrow denotes the addition of 10   	  M nitrite. Respiration rates (B) and ATP gen-
eration rates (C) before anoxia (green) and after anoxia in the presence of saline (blue) and nitrite (red). (D) Quantifi  cation of rate of ATP generation before 
and after anoxia. (E) Recovery of respiration rate with increasing concentrations (0  –  100   	  M) of nitrite added during anoxia. All experiments are means     
SEM of at least   n    3 independent experiments. *, P      0.01. RLU, relative light units.     JEM VOL. 204, September 3, 2007 
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of protein, suggesting that S-nitrosation of mitochondrial 
proteins could be responsible for nitrite-dependent cytopro-
tection. Consistent with this thesis, isolated mitochondria 
from rats treated with 480 nmol nitrite 24 h before isolation 
had detectable S-nitrosation (4.8      3 pmol/mg), whereas no 
signifi  cant S-nitrosation could be measured in saline-treated 
controls (  Fig. 6, C and D  ). 
  To further characterize the target of S-nitrosation, nitrite-
treated (20   	  M) mitochondria were fractionated by Superose 
6 gel fi  ltration, and SNO levels were measured by reductive 
chemiluminescence in each fraction. Signifi  cant S-nitrosation 
(    10 pmol) of the 900-kD mitochondrial fraction was observed 
in the nitrite-treated mitochondria, which includes complex I 
proteins and activity (  39  ), whereas no S-nitrosation was 
detected on this fraction in control mitochondria (  Fig. 6 E  ). 
potentially through the modulation of ROS production. We 
found that 200   	  M of the NO scavenger PTIO reversed the 
nitrite-dependent inhibition of complex I respiration after 
in vitro anoxia/reoxygenation, suggesting that the modifi  ca-
tion and subsequent inhibition of complex I was NO depen-
dent (  Fig. 5 F  ). 
  To identify the type of NO-dependent posttranslational 
modifi  cation, we measured protein S-nitrosothiols (SNOs), 
iron-nitrosyl, and   N  -nitrosamine complexes from isolated 
mitochondria treated with 0  –  100   	  M nitrite during anoxia/
reoxygenation using gas-phase ozone-based reductive chemi-
luminescence with both triiodide and copper/cysteine reduc-
tants (  Fig. 6, A and B  ).   Both reductive methods confi  rmed that 
nitrite treatment increased mitochondrial protein S-nitrosation 
in a concentration-dependent manner from 0.05  –  160 pmol/mg 
  Figure 5.     Nitrite treatment inhibits complex I. (A) Recovery of complex II  –  dependent respiratory rate in mitochondria that were untreated (Ctrl), 
treated with 10   	  M nitrite alone, 200   	  M diazoxide (Diaz), diazoxide and nitrite, 150   	  M glibenclamide (Glib), or glibenclamide and nitrite during anoxia. 
(B) Recovery of respiration of mitochondria respiring on succinate (complex II) or glutamate/malate (complex I) and ADP in the absence (green) and pres-
ence (red) of 10   	  M nitrite during anoxia/reoxygenation. (C) Absolute respiratory rates before and after anoxia of mitochondria from rats treated with 
nitrite (green) or saline (red) 24 h earlier. (D) Respiratory rates of mitochondria isolated from mice 5 h after they were subjected to hepatic I/R in vivo. 
(E) Complex I activity of isolated mitochondria treated with increasing concentrations of nitrite. (F) Recovery of complex I respiration rate in untreated 
mitochondria or treatment with 20   	  M nitrite, 100   	  M PTIO, or nitrite and PTIO. All experiments are means      SEM of   n    3 experiments. *, P      0.01.   2096 NITRITE PROTECTS FROM I/R INJURY BY REGULATING MITOCHONDRIA | Gladwin et al.
by this complex (  39, 43, 44  ). To determine whether nitrite-
dependent inhibition of complex I diminishes mitochondrial 
ROS generation, we subjected mitochondria to 30 min of 
anoxia in the presence and absence of nitrite 10   	  M and 
measured H  2  O  2   production by the oxidation of amplex red at 
reoxygenation. After I/R, H  2  O  2   production was increased in 
isolated mitochondria (9.9      0.5 nmol/min/mg) in compari-
son with preanoxic levels (3      0.5 nmol/min/mg). How-
ever, this increase was attenuated (4.5      1.4 nmol/min/mg) 
by nitrite treatment (  Fig. 7 A  ).   
  The Fe-S containing mitochondrial enzyme aconitase is 
highly susceptible to oxidative damage. We measured the ac-
tivity of this enzyme as an index of oxidative protein damage, 
Although nitrite appeared to S-nitrosate additional targets on 
the electron transport chain, these data suggest that nitrite-
dependent S-nitrosation and NO-mediated thiol oxidation of 
complex I are responsible for the inhibition of complex I ac-
tivity after anoxia-reoxygenation both in vivo and in vitro. 
  Nitrite-dependent complex I inhibition limits reperfusion 
ROS generation and aconitase inactivation 
  Complex I is a primary site of mitochondrial ROS produc-
tion, with superoxide generation by forward and reverse 
electron transport (  41, 42  ). Inhibition of complex I may con-
fer cytoprotection potentially because of the limitation of ox-
idative protein damage by the inhibition of ROS production 
  Figure 6.     Nitrite S-nitrosates complex I. (A) Representative chemiluminescence trace of nitrite-treated mitochondria injected into triiodine before 
and after pretreatment with mercuric chloride (+Hg). (B) Quantitation of S-nitrosation in mitochondria from A (red) and an identical experiment using 
copper (I)/cysteine as a reductant instead of triiodine (blue). (C) Representative copper (I)/cysteine  –  based chemiluminescence trace of mitochondria iso-
lated from rats treated with 480 nmol of saline or nitrite 24 h earlier. (D) Quantifi  cation of traces similar to those shown in C. (E) Protein was extracted 
from rat liver mitochondria and loaded onto a Superose 6 size-exclusion column. The SNO and complex I activity of each fraction was then determined and 
are represented as picomoles of SNO per fraction and complex I activity of the neat fractions, respectively. Mitochondria subjected to ischemia without 
NO  2        treatment resulted in no SNO detection (not depicted). All experiments are means      SEM of at least   n    3 independent experiments. *, P      0.01.   JEM VOL. 204, September 3, 2007 
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which the I/R-induced increase in oxidative damage was 
diminished by nitrite treatment either acutely or 24 h before 
the ischemic episode (48 nmol;   Fig. 7 C  ). 
  Nitrite treatment prevents opening of the permeability 
transition pore and cytochrome c release 
  Opening of the mitochondrial permeability transition pore has 
been linked to the release of cytochrome c and is important 
with a lowered activity indicating greater oxidative damage. 
Consistent with a nitrite-dependent decrease in ROS pro-
duction, mitochondria subjected to anoxia/reoxygenation 
sustained more oxidative damage (13      1.1 mU/mg of protein) 
than control mitochondria (28      4 mU/mg), whereas those 
treated with nitrite during anoxia were signifi  cantly protected 
(18      1.8 mU/mg;   Fig. 7 B  ). These eff  ects translated to en-
tire livers taken from mice 5 h after in vivo hepatic I/R, in 
  Figure 7.     Nitrite decreases oxidative damage in mitochondria. (A) Representative traces of ROS production measured by amplex red in mitochon-
dria without substrate (light blue) in the presence of glutamate/malate and ADP before anoxia/reoxygenation (green), and after anoxia/reoxygenation in 
the presence (red) and absence (blue) of 20   	  M nitrite. (B) Aconitase activity of mitochondria during normoxia and after anoxia/reoxygenation in the 
presence and absence of 20   	  M nitrite. (C) Aconitase activity in liver tissue from mice 5 h after they were subjected to hepatic I/R or sham surgery in the 
presence and absence of 48 nmol of acute or preconditioning nitrite. (D) Representative traces of calcium-induced pore opening of mitochondria sub-
jected to anoxia/reoxygenation in the presence of 20   	  M nitrite. Traces are in the absence of calcium (black), in the absence of nitrite treatment (red), or 
with nitrite treatment (blue). (E) Western blot analysis of cytochrome c remaining in mitochondria from the conditions shown in D. All experiments are 
means      SEM of at least   n    3 independent experiments. *, P      0.01; #, P      0.05.   2098 NITRITE PROTECTS FROM I/R INJURY BY REGULATING MITOCHONDRIA | Gladwin et al.
oxidative protein damage to the electron transport chain, cy-
tochrome c release, and cellular and tissue infarction. 
  Interestingly, NO production has been shown to evoke 
acute (classical) preconditioning and is required in the de-
layed ischemic preconditioning cell-survival program (  19, 49  ). 
This occurs through increased endothelial NOS activity after 
acute ischemic preconditioning and via induction of iNOS 
24 h later for remote preconditioning (  50  ). Relevant to the 
current study, nitrite levels increase in a biphasic manner 
after both acute and delayed ischemic preconditioning, with 
maximal increases observed during the I/R tolerant periods 
(  50  ). In this study, we show that administration of nitrite at 
either of these preconditioning time points confers potent 
cytoprotection in vivo and modulates mitochondrial func-
tion. In addition, previous studies have shown complex I 
inhibition (  51  ), as well as an increase in mitochondrial 
S-nitrosation (  39  ), after ischemic preconditioning of the rat 
heart. Given these data, it is intriguing to consider that ni-
trite could serve as both an endogenous reservoir for NO 
production and an eff   ector molecule mediating the cell-
survival eff  ects of both acute and delayed ischemic precon-
ditioning. Consistent with such NO-dependent signaling, 
in initiating the mitochondrial apoptotic pathway. Because 
oxidants have been shown to sensitize the permeability 
transition pore (  45, 46  ), we determined whether the cyto
protective eff  ects of nitrite could in part be caused by nitrite-
dependent protection against pore opening after I/R. Iso-
lated mitochondria were subjected to 30 min of anoxia in 
the presence or absence of 20   	  M nitrite, 10   	  M calcium 
was added to stimulate pore opening during reperfusion, and 
mitochondrial swelling was spectrophotometrically moni-
tored as a measure of pore opening. In the presence of 
calcium, mitochondrial pore opening was facilitated, as in-
dicated by a rapid drop in absorbance. However, in mito-
chondria treated with nitrite during anoxia, pore opening 
was delayed after the addition of calcium and occurred at 
a considerably slower rate and to a lesser extent than in the 
absence of nitrite (  Fig. 7 D  ). 
  To assess whether nitrite limits cytochrome c release, the 
mitochondria were centrifuged 1 min after the addition of 
calcium, and the amount of cytochrome c remaining in the 
mitochondria was measured. In control mitochondria, cal-
cium-induced pore opening elicited the loss of cytochrome c 
from control mitochondria, whereas nitrite-treated mitochon-
dria were protected from cytochrome c release (  Fig. 7 E  ). 
  Oral nitrite administration confers resistance to hepatic 
and cardiac I/R injury 
  Several chemical agents, including rotenone and amobarbi-
tol, are known to inhibit complex I and confer protection to 
mitochondria after I/R. However, these agents are not prac-
tical therapeutic candidates and certainly are not naturally 
occurring compounds. Conversely, nitrite forms from the 
  reduction of dietary nitrate by oral bacterial fl  ora and is a po-
tential cardioprotective agent in the nitrate-rich Mediterra-
nean diet (  47, 48  ). To evaluate whether oral nitrite would 
promote preconditioning cytoprotection after I/R injury, 
we next tested oral dosing of nitrite. To begin to explore this, 
nitrite or saline vehicle was administered to mice via oral 
gavage 24 h before in vivo hepatic or cardiac I/R. Both liver 
and heart I/R were evaluated 24 h after a single oral gavage 
of 200   	  l of 100 mg/liter sodium nitrite. This would corre-
spond to 9.6   	  mol of sodium nitrite per kilogram. Because 
the total body load of nitrite after ingestion of a nitrate-rich 
meal (i.e., 100 g of spinach) amounts to     1   	  mol/kg (  47  ), 
our dose is consistent with the daily nitrite intake on the 
Mediterranean diet. This regimen replicated the cytoprotec-
tion evoked by the earlier intraperitoneal administration of 
nitrite used in the previous experiments performed in this 
study (  Fig. 8, A and B  ).   
    DISCUSSION   
  These data demonstrate that nanomole doses of nitrite mediate 
both acute cytoprotection and mimic delayed preconditioning 
in the heart and liver in vivo. Mechanistically, both acute and 
delayed nitrite-dependent cytoprotection occur at the mito-
chondrial level, with the inhibition of mitochondrial complex I 
by S-nitrosation limiting mitochondrial ROS generation, 
  Figure 8.     Hepatic and myocardial I/R injury are attenuated in mice 
after oral nitrite therapy. (A) The effects of oral nitrite preconditioning 
(PC) on the severity of hepatic I/R injury (measured as aspartate amino-
transferase [AST] and ALT) in mice. Mice received nitrite via oral gavage at 
24 h before 45 min of hepatic ischemia and 5 h of reperfusion. Numbers 
for each group are shown inside the bars. (B) Bar graph of oral nitrite 
preconditioning and myocardial I/R injury in mice. Mice received oral 
nitrite at 24 h before 30 min of ischemia and 24 h of reperfusion. The 
myocardial area-at-risk (AAR) per total left ventricle (LV) was not signifi  -
cantly different between study groups (NS). The myocardial infarct size 
(Inf) per area-at-risk was signifi  cantly (P      0.0001) reduced in the oral 
nitrite preconditioning group when compared with the oral vehicle group. 
Eight animals were investigated in each group.     JEM VOL. 204, September 3, 2007 
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  The chemistry of nitrite-dependent nitrosation of com-
plex I will also require further study, considering the fact 
that the NO radical will not directly nitrosate reduced thiol 
(one-electron oxidation is required). There are several pos-
sibilities that might be unique to the mitochondria. First, di-
rect nitrosation of thiols by nitrous acid: the inner membrane 
space has an estimated pH of     7.2, with the matrix having 
a pH of     7.9. Although minimal nitrous acid should form 
at pH 7.2 (the pKa of nitrite is     3.2), any nitrous acid that 
formed would occur in the inner membrane space and po-
tentially at complexes I, III, IV, and V, which actively pump 
protons. The hydrophobic transmembrane environment of 
these complexes would stabilize both nitrous acid, N  2  O  3  , 
and the formed SNO. Second, NO production from nitrite 
reduction could secondarily react with nitrogen dioxide or 
superoxide formed from mitochondrial oxidation pathways 
and could form nitrosating intermediates such as N  2  O  3   or 
ONOO       . Third, we have recently found that nitrite binds 
to and reacts with metheme proteins, such as methemoglo-
bin, to produce an NO  2   radical  –  like intermediate that can 
then react with NO to form N  2  O  3   (58); N  2  O  3   would di-
rectly nitrosate complex I. This would provide a metal-based 
pathway to S-nitrosation by nitrite. Although these pathways 
remain theoretical, the mechanisms of S-nitrosation by nitrite 
are currently an active area of research in the NO fi  eld. 
  It is tempting to speculate that nitrite is the endogenous 
molecule that regulates ischemic ROS formation at com-
plex I after reperfusion. Such an innate mechanism could repre-
sent an evolved response to limit tissue injury during birth 
(for the fetus and mother), traumatic hemorrhage, and ex-
treme exercise. From a therapeutic standpoint, nitrite would 
represent an ideal candidate to confer mitochondrial and, by 
extension, cellular resilience to I/R injury through the partial 
inhibition of complex I. The therapeutic potential of nitrite 
is underscored as follows: (a) this anion is a chemically stable 
endogenous reservoir for NO, (b) the required therapeutic 
concentration is in the nanomolar range, and (c) it is also 
readily available in diet (i.e., the Mediterranean diet) and, as 
shown in our study, its protective eff  ect is clearly observed 
with oral intake. 
  Consistent with an innate physiological role for nitrite in 
modulating the stress response, the cytoprotective eff  ects of 
nitrite in the heart and liver are measurable at nitrite doses 
    1.2 nmol in murine models of myocardial infarction and 
hepatic I/R (  8  ). These doses increase plasma nitrite levels by 
    10% and are consistent with increases observed after the in-
gestion of a standard leafy green salad (  47, 48  ) or after regular 
moderate exercise (  59  –  61  ). Furthermore, mice with dimin-
ished basal plasma nitrite concentrations are more susceptible 
to I/R injury, an eff  ect that is attenuated by administration of 
exogenous nitrite (  11  ). These data suggest that a diet rich in 
nitrate and nitrite may have profound cytoprotective eff  ects 
and, most provocatively, could constitute the   “  active  ”   ingre-
dient of the cardioprotective Mediterranean diet (  47, 48  ). 
  In conclusion, we have shown that nitrite potently me-
diates cytoprotection after I/R of the mammalian heart and 
PTIO, a direct NO scavenger, has been observed to inhibit the 
cytoprotective eff  ects of nitrite in cardiac (  10, 20  ), liver (  20  ), 
and brain (  9  ) I/R. 
  NO itself has been shown to directly protect cultured rat 
neonatal cardiomyocyte mitochondria when administered in 
time periods compatible with both classical and delayed pre-
conditioning (  52, 53  ). Previous studies show that NO modu-
lates mitochondrial Ca  2+   handling that in turn diminishes 
reoxygenation-associated Ca  2+   overload (  52, 53  ). In this 
manuscript, we demonstrate that nitrite administration di-
rectly modifi  es the electron transfer chain complex I activity 
in association with S-nitrosation of this complex. This is asso-
ciated with blunted reperfusion/reoxygenation ROS-mediated 
injury. The putative mechanisms that could confer this pheno-
type include the direct inhibition of complex I  –  generated 
ROS or via the modest reduction in the mitochondrial mem-
brane potential that may result from the partial inhibition of 
complex I activity (  5  ). 
  An apparent paradox is evident with respect to complex I 
inhibition and ROS generation. In brief, in an aerobic envi-
ronment with adequate oxidative phosphorylation, substrate, 
and reducing equivalents, the direct inhibition of complex I 
with either rotenone (  54  ) or by preformed SNOs (  40  ) results 
in complex I  –  derived ROS production. Conversely, when 
complex I is inhibited in the context of I/R by rotenone, the 
production of ROS is decreased during the oxidation of 
complex I substrate, in parallel with the preservation of mito-
chondrial content and the rate of oxidation through cyto-
chrome c oxidase (  55  ). This mitochondrial   “  protective  ”   
response to complex I inhibition during ischemia has been 
replicated by the use of amobarbital (a reversible inhibitor of 
complex I) (  43  ), by S-nitrosoglutathione  –  dependent transni-
trosation in the Langendorff   perfused heart (  39  ), and in this 
study, by the naturally occurring anion nitrite. Collectively, 
these data suggest that transient inhibition of complex I in the 
I/R milieu can have protective eff  ects associated with re-
duced ROS production during reperfusion. In contrast, 
chronic inhibition of complex I under an otherwise physio-
logic milieu can be cytotoxic and associated with elevated 
ROS production (  56  ). 
  Interestingly, nitrite appears to be unique among the 
aforementioned agents in that it does not inhibit complex I 
activity during normal physiology but only inhibits complex I 
activity in the setting of I/R injury. These data suggest that 
the modifi  cation of complex I by these near physiological 
concentrations of nitrite is dynamic and only operational in 
the setting of ischemia. The mechanisms whereby low-dose 
nitrite-mediated modifi  cation of complex I is   “  fi  ne-tuned  ”   
to have no appreciable inhibitory eff  ect under normal ho-
meostatic conditions but suffi   cient inhibitory eff  ects in the 
context of hypoxic or redox stress are currently unknown 
and require further investigations. However, such dynamic 
inhibition of complex I allows for sustained mitochondrial 
oxidative phosphorylation through complex II during I/R 
while limiting ROS generation, mitochondrial calcium over-
load, and the release of cytochrome c (  37, 52, 57  ). 2100 NITRITE PROTECTS FROM I/R INJURY BY REGULATING MITOCHONDRIA | Gladwin et al.
100   	  M NADH in the presence of 10   	  M coenzyme Q  1   in the presence 
and absence of 25   	  M rotenone. 
  Detection of S-nitrosation.     To measure S-nitrosation, 10 mg of isolated 
mitochondria treated with nitrite was lysed with a solution of 1% NP-40 and 
100   	  M diethylenetriamene pentaacetate (DTPA). Half of the sample was 
immediately injected into copper/cysteine-based reductive chemilumines-
cence, which is specifi  c for S-nitrosated protein adducts. The other half of 
the protein was divided into three parts: one left untreated, one treated with 
10% acidifi  ed sulfanilamide to eliminate nitrite, and one treated with 5 mM 
mercuric chloride and 10% acidifi  ed sulfanilamide (v/v) to eliminate nitrite 
and SNOs. The three fractions were injected into a vessel containing triio-
dine and connected inline to an NO chemiluminescence detector (Seivers), 
as previously described (  64  ). 
  ROS generation.     H  2  O  2   generation was spectrophotometrically assayed by 
monitoring the oxidation of amplex red to product resofurin at 585 nm us-
ing the Amplex Red Hydrogen Peroxide/Peroxidase assay kit (Invitrogen). 
  Mitochondrial fractionation.     3 mg of mitochondrial protein was extracted 
in 60   	  l of buff  er (10 mM Hepes, pH 7.4, 1 mM EDTA, 100   	  M DTPA, 
1.6% lauryl-maltoside). 25   	  l of sample (    1.25 mg of protein) was loaded 
onto a 1   
   24 cm Superose 6 size-exclusion column, run at a fl  ow rate of 
0.5 ml/min, with the running buff  er (10 mM Hepes, pH 7.4, 1 mM EDTA, 100 
  	  M DTPA). 500-  	  l fractions were collected, and 475   	  l was immediately 
subjected to chemiluminescent SNO analysis, as described in Detection of 
S-nitrosation, with the remaining 25   	  l being used for protein determination 
by a bicinchoninic acid–based protein assay. The column was calibrated by run-
ning high-range molecular mass standards (68  –  669 kD; GE Healthcare). 
  Aconitase activity.     Mitochondria were lysed by three cycles of freeze/
thaw, and aconitase activity was measured by spectrophotometrically moni-
toring the formation of NADPH at 340 nm using the Bioxytech Aconitase-
340 kit (Oxis Research). 
  Permeability transition pore opening and cytochrome c release.     After 
being subjected to anoxia/reoxygenation in the presence or absence of 
nitrite, 1 mg/ml of mitochondria was given fresh substrate and spectrophoto-
metrically monitored at 540 nm at 37  °  C. After 100 s, 10   	  M calcium 
chloride was added to each cuvette, and monitoring was continued. 1 min 
after the addition of calcium, pore opening was suspended by the addition of 
500   	  M EGTA and 20   	  M cyclosporine A, and the mitochondria were 
centrifuged at 10,000   g   for 5 min. The mitochondrial pellets were subjected 
to Western blot analysis using an anticytochrome c antibody (Santa Cruz 
Biotechnology, Inc.). 
  Oral nitrite studies.     Sodium nitrite was dissolved in saline at a concentra-
tion of 100 mg/liter. 24 h before either hepatic or myocardial ischemia, mice 
were administered 200   	  l of the 100 mg/liter sodium nitrite stock solution 
or vehicle (saline) orally with the aid of a 20-gauge oral gavage needle. The 
hepatic and myocardial I/R injuries were performed as described in Hepatic 
I/R and Myocardial infarction. 
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liver at the mitochondrial level through the transient in-
hibition of complex I and subsequent limitation of oxida-
tive damage. The acute and remote temporal windows of 
nitrite-dependent cytoprotection suggest that nitrite may be 
a central mediator in ischemic preconditioning. Collectively, 
these studies reveal a global role for nitrite in the regulation 
of ischemic responses at the subcellular level. Finally, its ef-
fi  cacy as an oral preparation at near physiologic doses suggests 
a role for nitrite as a dietary cardioprotective agent. 
  MATERIALS AND METHODS 
  Chemicals.     All reagents were obtained from Sigma-Aldrich unless other-
wise noted. 
  Animals.     8  –  10-wk-old male C57BL6/J mice (The Jackson Laboratory) 
were used in accordance with the Animal Care and Use Committee of AE-
COM. Male Sprague-Dawley rats (250-500 g; Harlan) were used in accor-
dance with the Animal Care and Use Committee of the National Heart 
Lung Blood Institute. 
  Hepatic I/R.     Mice were anesthetized with 100 mg/kg ketamine and 8 mg/kg 
xylazine injected intraperitoneally. A midline laparotomy incision was 
performed, and mice were heparinized (100   	  g/kg intraperitoneally) to prevent 
blood clotting. Microaneurysm clamps were used to completely clamp the 
hepatic artery and portal vein, causing ischemia of the left lateral and median 
lobes of the liver, as previously described (  8  ). The liver was kept moist with 
normal saline for 45 min, after which the microaneurysm clamp was removed 
to allow reperfusion. Mice were sutured, and serum was collected 5 h later 
for measurement of liver transaminase levels. 
  Myocardial infarction.     Mice were anesthetized by injection of 50 mg/
kg ketamine and 50 mg/kg pentobarbital and were then intubated with 
polyethylene tubing connected to a rodent ventilator, after which the re-
spiratory rate was set to 122 breaths per minute. A median sternectomy 
was performed, and the left main coronary artery was completely ligated 
witha 7-0 silk suture mounted on a tapered needle, as previously described 
(  8  ). After 30 min, the suture was removed, and animals were reperfused 
for 24 h. 
  Mitochondrial isolation and respiration.     Liver mitochondria were iso-
lated by diff  erential centrifugation in a buff  er (250 mM sucrose, 10 mM Tris, 
1 mM EGTA, pH 7.4) at 4  °  C, as previously described (  62  ). To measure 
respiration of isolated mitochondria, 1 mg/ml of protein was suspended in 
respiration buff  er (120 mM KCl, 25 mM sucrose, 10 mM Hepes, 1 mM 
EGTA, 1 mM KH  2  PO  4  , 5 mM MgCl  2  ) in a stirred, sealed chamber fi  t with 
a Clark-type oxygen electrode (Instech Corp.) connected to a data recording 
device (DATAQ Systems). 
  In vitro anoxia/reoxygenation.     The in vitro anoxia/reoxygenation pro-
tocol was adapted from Ozcan et al. (  63  ). State 3 respiration was initiated, 
and mitochondria were allowed to consume oxygen until the chamber be-
came anoxic. The mitochondria were left in this anoxic state for 30 min. To 
reoxygenate, mitochondria were centrifuged and resuspended in oxygenated 
buff  er containing fresh substrate and ADP and allowed to respire once again. 
Postanoxic respiratory rate was expressed as a percentage of preanoxic rate 
and called recovery of respiration. 
  ATP generation.     ATP synthesis in isolated mitochondria suspended in 
respiration buff  er with 15 mM succinate and 0.5 mM ADP was measured by 
monitoring the luminescence of luciferase/luciferin over time using the 
ATP detection kit from Invitrogen. 
  Complex I activity.     Complex I activity was determined in isolated mito-
chondria by spectrophotometrically (340 nm) monitoring the oxidation of JEM VOL. 204, September 3, 2007 
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